Literature DB >> 33408194

Structural airway imaging metrics are differentially associated with persistent chronic bronchitis.

Surya P Bhatt1,2, Sandeep Bodduluri3,2, Abhilash S Kizhakke Puliyakote4, Elizabeth C Oelsner5, Arie Nakhmani2,6, David A Lynch7, Carla G Wilson8, Spyridon Fortis9, Victor Kim10.   

Abstract

BACKGROUND: Chronic bronchitis (CB) is strongly associated with cigarette smoking, but not all smokers develop CB. We aimed to evaluate whether measures of structural airway disease on CT are differentially associated with CB.
METHODS: In smokers between ages 45 and 80 years, and with Global Initiative for Obstructive Lung Disease stages 0-4, CB was defined by the classic definition. Airway disease on CT was quantified by (i) wall area percent (WA%) of segmental airways; (ii) Pi10, the square root of the wall area of a hypothetical airway with 10 mm internal perimeter; (iii) total airway count (TAC) and (iv) airway fractal dimension (AFD), a measure of the complex branching pattern and remodelling of airways. CB was also assessed at the 5-year follow-up visit.
MEASUREMENTS AND MAIN RESULTS: Of 8917 participants, 1734 (19.4%) had CB at baseline. Airway measures were significantly worse in those with CB compared with those without CB: WA% 54.5 (8.8) versus 49.8 (8.3); Pi10 2.58 (0.67) versus 2.28 (0.59) mm; TAC 156.7 (81.6) versus 177.8 (91.1); AFD 1.477 (0.091) versus 1.497 (0.092) (all p<0.001). On follow-up of 5517 participants at 5 years, 399 (7.2%) had persistent CB. With adjustment for between-visits changes in smoking status and lung function, greater WA% and Pi10 were associated with significantly associated with persistent CB, adjusted OR per SD change 1.75, 95% CI 1.56 to 1.97; p<0.001 and 1.66, 95% CI 1.42 to 1.86; p<0.001, respectively. Higher AFD and TAC were associated with significantly lower odds of persistent CB, adjusted OR per SD change 0.76, 95% CI 0.67 to 0.86; p<0.001 and 0.69, 95% CI 0.60 to 0.80; p<0.001, respectively.
CONCLUSIONS: Higher baseline AFD and TAC are associated with a lower risk of persistent CB, irrespective of changes in smoking status, suggesting preserved airway structure can confer a reserve against CB. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COPD pathology

Mesh:

Year:  2021        PMID: 33408194      PMCID: PMC8225550          DOI: 10.1136/thoraxjnl-2020-215853

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  45 in total

1.  Flow and particle deposition patterns in a realistic human double bifurcation airway model.

Authors:  L T Choi; J Y Tu; H F Li; F Thien
Journal:  Inhal Toxicol       Date:  2007-02       Impact factor: 2.724

2.  Signs of Gas Trapping in Normal Lung Density Regions in Smokers.

Authors:  Sandeep Bodduluri; Joseph M Reinhardt; Eric A Hoffman; John D Newell; Hrudaya Nath; Mark T Dransfield; Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

3.  Computed Tomography Measure of Lung at Risk and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Authors:  Surya P Bhatt; Sandeep Bodduluri; Eric A Hoffman; John D Newell; Jessica C Sieren; Mark T Dransfield; Joseph M Reinhardt
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

4.  The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.

Authors:  Victor Kim; Huaqing Zhao; Elizabeth Regan; MeiLan K Han; Barry J Make; James D Crapo; Paul W Jones; Jeffrey L Curtis; Edwin K Silverman; Gerard J Criner
Journal:  Chest       Date:  2019-05-15       Impact factor: 9.410

5.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers.

Authors:  Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han
Journal:  Respir Med       Date:  2013-11-15       Impact factor: 3.415

6.  Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

Authors:  Bipen D Patel; Harvey O Coxson; Sreekumar G Pillai; Alvar G N Agustí; Peter M A Calverley; Claudio F Donner; Barry J Make; Nestor L Müller; Stephen I Rennard; Jørgen Vestbo; Emiel F M Wouters; Melanie P Hiorns; Yasutaka Nakano; Patricia G Camp; Paola V Nasute Fauerbach; Nicholas J Screaton; Edward J Campbell; Wayne H Anderson; Peter D Paré; Robert D Levy; Stephen L Lake; Edwin K Silverman; David A Lomas
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

7.  Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk.

Authors:  S Guerra; D L Sherrill; C Venker; C M Ceccato; M Halonen; F D Martinez
Journal:  Thorax       Date:  2009-07-05       Impact factor: 9.139

8.  Airway fractal dimension predicts respiratory morbidity and mortality in COPD.

Authors:  Sandeep Bodduluri; Abhilash S Kizhakke Puliyakote; Sarah E Gerard; Joseph M Reinhardt; Eric A Hoffman; John D Newell; Hrudaya P Nath; MeiLan K Han; George R Washko; Raúl San José Estépar; Mark T Dransfield; Surya P Bhatt
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

9.  Airway wall thickening on CT: Relation to smoking status and severity of COPD.

Authors:  Jean-Paul Charbonnier; Esther Pompe; Camille Moore; Stephen Humphries; Bram van Ginneken; Barry Make; Elizabeth Regan; James D Crapo; Eva M van Rikxoort; David A Lynch
Journal:  Respir Med       Date:  2018-11-20       Impact factor: 3.415

10.  Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.

Authors:  Jin Hwa Lee; Michael H Cho; Craig P Hersh; Merry-Lynn N McDonald; James D Crapo; Per S Bakke; Amund Gulsvik; Alejandro P Comellas; Christine H Wendt; David A Lomas; Victor Kim; Edwin K Silverman
Journal:  Respir Res       Date:  2014-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.